Literature DB >> 7819071

Purification and characterization of human platelet von Willebrand factor.

S B Williams1, L P McKeown, H Krutzsch, K Hansmann, H R Gralnick.   

Abstract

Platelet von Willebrand factor (vWf) was purified from human platelet concentrates. The multimeric structure of the purified platelet vWf was similar to that observed in the initial platelet lysate, and, like the platelet lysate, the purified platelet vWf contained higher molecular weight multimers than plasma vWf. The apparent molecular weight of the reduced platelet vWf subunit was similar to the plasma vWf subunit. The N-terminal amino acid of the purified platelet and plasma vWf was blocked. In concentration dependent binding to botrocetin- or ristocetin-stimulated platelets, 125I-plasma vWf bound with a higher affinity than platelet. The ristocetin cofactor activity per mg of purified plasma vWf was 5-fold greater than the platelet vWf activity. Platelet and plasma vWf bound to collagen with similar affinities; however, platelet vWf bound to thrombin-stimulated platelets and to heparin with a higher affinity than plasma vWf. The differences in the binding affinity(s) of plasma and platelet vWf to platelet GPIb and GPIIb/IIIa and extracellular matrix proteins may reflect different roles for plasma and platelet vWf in the initial stages of haemostasis and thrombosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7819071     DOI: 10.1111/j.1365-2141.1994.tb05077.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

1.  Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis.

Authors:  S Kanaji; S A Fahs; Q Shi; S L Haberichter; R R Montgomery
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

Review 2.  Platelet von Willebrand factor in inherited and acquired bleeding disorders.

Authors:  P M Mannucci
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

3.  A revised model of platelet aggregation.

Authors:  S Kulkarni; S M Dopheide; C L Yap; C Ravanat; M Freund; P Mangin; K A Heel; A Street; I S Harper; F Lanza; S P Jackson
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

4.  The important role of von Willebrand factor in platelet-derived FVIII gene therapy for murine hemophilia A in the presence of inhibitory antibodies.

Authors:  Q Shi; J A Schroeder; E L Kuether; R R Montgomery
Journal:  J Thromb Haemost       Date:  2015-06-11       Impact factor: 5.824

5.  Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.

Authors:  E Berntorp; B Fuchs; M Makris; R Montgomery; V Flood; J S O'Donnell; A B Federici; D Lillicrap; P James; U Budde; M Morfini; P Petrini; S Austin; C Kannicht; V Jiménez-Yuste; C Lee
Journal:  Haemophilia       Date:  2013-03       Impact factor: 4.287

6.  Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.

Authors:  Nirav Dhanesha; Prem Prakash; Prakash Doddapattar; Ira Khanna; Molly J Pollpeter; Manasa K Nayak; Janice M Staber; Anil K Chauhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-21       Impact factor: 8.311

7.  Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.

Authors:  Prakash Doddapattar; Nirav Dhanesha; Mehul R Chorawala; Chandler Tinsman; Manish Jain; Manasa K Nayak; Janice M Staber; Anil K Chauhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-18       Impact factor: 8.311

8.  Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease.

Authors:  Alessandra Casonato; Maria Grazia Cattini; Viviana Daidone; Elena Pontara; Antonella Bertomoro; Paolo Prandoni
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

9.  Evaluation of von Willebrand factor concentrates by platelet adhesion to collagen using an in vitro flow assay.

Authors:  Anne Riddell; Saravanan Vinayagam; Keith Gomez; Mike Laffan; Tom McKinnon
Journal:  Res Pract Thromb Haemost       Date:  2018-12-07

10.  Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance.

Authors:  Soracha E Ward; Jamie M O'Sullivan; Alan B Moran; Daniel I R Spencer; Richard A Gardner; Jyotika Sharma; Judicael Fazavana; Marco Monopoli; Thomas A J McKinnon; Alain Chion; Sandra Haberichter; James S O'Donnell
Journal:  Haematologica       Date:  2022-03-01       Impact factor: 9.941

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.